As a news reporter, Ayisha Sharma focuses on the UK and Europe biopharma space and has an interest in psychiatric drug R&D. Ayisha joined Endpoints from Scrip, where she spent nearly two years covering the commercial implications of clinical trial readouts, drug approvals and industry dealmaking. Prior to this, she was an investigative journalist at GlobalData Insights. Ayisha holds an MA in Philosophy from University College London as well as a diploma in multimedia journalism. In her spare time, she enjoys running, yoga and watching horror films.
Sign up for free to read a limited number of articles each month.About You
Pick what newsletters get delivered to your inbox each week.
Want unlimited access? Sign up for a premium subscription plan.